GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
Geneuro has raised €29M across 3 funding rounds, most recently a round in Feb 2024. Based in Geneva, Switzerland; founded 2006; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-02-06 | Other | €5.0M | — | View deal → |
| 2021-07-16 | Other | €6.0M | — | View deal → |
| 2020-01-31 | Other | €18M | — | View deal → |
